NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1–NEDD8 pathway

NEDP1 acts as a tumor suppressor in HB by modulating the NEDDylation status of key regulatory proteins, particularly CAND1. Restoration of NEDP1 activity suppresses tumorigenesis and metastasis, underscoring the NEDDylation pathway as a promising therapeutic target. CAND1 is proposed as a potential prognostic biomarker and actionable oncogenic driver in HB.

Authors

Institutions

Publication Details

Journal
Hepatology
Published
2025-11-14
DOI
https://doi.org/10.1097/hep.0000000000001614
Primary Topic
Cell Adhesion Molecules Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1–NEDD8 pathway

José J.G. Marı́n, Alfonso Castaneda, Clàudia Gil‐Pitarch, Bruce Wang et al.
Hepatology
Cell Adhesion Molecules Research
article

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1–NEDD8 pathway

José J.G. Marı́n, Alfonso Castaneda, Clàudia Gil‐Pitarch, Bruce Wang, Dimitris P. Xirodimas, Matías A. Ávila, Zbyněk Heger, Rubén Nogueiras, Pau Sancho‐Bru, María Mercado-Gómez, Naroa Goikoetxea‐Usandizaga, Irene González‐Recio, Marina Serrano‐Maciá, Abhishek Murti, Sofía Lachiondo‐Ortega, Claudia M. Rejano-Gordillo, Miguel Ángel Merlos Rodrigo, Maitane Asensio, Ugo Mayor, Maria Luz Martínez‐Chantar, Teresa C. Delgado, Maite G. Fernández‐Barrena, Álvaro Del Río-Álvarez, Carolina Armengol, Diego F. Calvisi, Jon Ander Barrenechea-Barrenechea, L. Estefanía Zapata-Pavas, Patricia Peña-Sanfélix, Hana Michalkova, Elise Lelou
article en

Abstract

NEDP1 acts as a tumor suppressor in HB by modulating the NEDDylation status of key regulatory proteins, particularly CAND1. Restoration of NEDP1 activity suppresses tumorigenesis and metastasis, underscoring the NEDDylation pathway as a promising therapeutic target. CAND1 is proposed as a potential prognostic biomarker and actionable oncogenic driver in HB.

Hepatology
Ikerbasque (ES), Centre National de la Recherche Scientifique (FR), University of the Basque Country (ES), University of California, San Francisco (US), Universidad de Salamanca (ES), Université de Montpellier (FR), Universidade de Santiago de Compostela (ES), Instituto de Salud Carlos III (ES), Navarre Institute of Health Research (ES), CIC bioGUNE (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Instituto de Investigación Biomédica de Salamanca (ES), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), Instituto de Investigación Sanitaria de Santiago (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Mendel University in Brno (CZ), University of Regensburg (DE), Universidad de Navarra (ES)
Openalex Percentile: Top 56%
Cell Adhesion Molecules Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.